MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $932,184 | +290.9% | 21,400 | +224.2% | 0.01% | +350.0% |
| Q2 2023 | $238,458 | -49.8% | 6,600 | -2.9% | 0.00% | -60.0% |
| Q3 2022 | $474,912 | +92.3% | 6,800 | +126.7% | 0.01% | +150.0% |
| Q1 2022 | $247,000 | -57.9% | 3,000 | -25.0% | 0.00% | -50.0% |
| Q4 2021 | $587,000 | +21.0% | 4,000 | +33.3% | 0.00% | -20.0% |
| Q2 2021 | $485,000 | -19.2% | 3,000 | -14.3% | 0.01% | -16.7% |
| Q1 2021 | $600,000 | -9.0% | 3,500 | +16.7% | 0.01% | -14.3% |
| Q4 2020 | $659,000 | +16.6% | 3,000 | -11.8% | 0.01% | +16.7% |
| Q3 2020 | $565,000 | +5.2% | 3,400 | -27.7% | 0.01% | 0.0% |
| Q2 2020 | $537,000 | +39.8% | 4,700 | -6.0% | 0.01% | +20.0% |
| Q1 2020 | $384,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |